MedCity News February 17, 2025
Merck’s implementation of artificial intelligence in drug research includes analyzing years of existing Merck clinical data to help identify which drugs and drug combinations to pursue. But Merck executive Matt Studney said AI is tool to help, not replace humans.
Technology is changing the way pharmaceutical companies discover and develop new drugs. For Matt Studney, who joined Merck as a chemical engineer, technology changed the course of his career. In 2017, the pharma giant was one of several healthcare businesses breached by a cyberattack. Studney was tasked with leading the company’s recovery.
Studney said the experience gave him a deep, inside look into Merck’s technology stack. Now, as vice president of information technology of Merck Research Labs, his responsibilities include...
Today's Sponsors
Today's Sponsor